Yiling Pharma to Spend $22 Million on Three Drug Collaborations
Shijiazhuang Yiling Pharmaceutical announced plans to invest 138 million RMB ($22 million) into collaborations with other China pharmas to develop innovative drugs. Last summer, Yiling conducted a very popular IPO on the ChiNext exchange. Because of high investor demand, Yiling raised the price of its shares by one-third, ultimately raising $348 million. The company is now investing some of the “unexpected” proceeds into innovation. More details.... Stock Symbol: (SHE: 002603) Share this with colleagues: var switchTo5x=true; stLight.options({publisher:'d7871f5b-67bc-4d30-b66f-1465d0b97213'});  
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Six Financial
Postage Rates Bots go here